Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

TPEX/6815 stock hub

TPEX/6815 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6815is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6815

In the news

Latest news · TPEX/6815

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-12.1

P25 -16.2P50 0.3P75 9.8

ROIC-16.2

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6815 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

191

Groups with data

Currency

TWD

Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees Change	2%
Employees Change Percent	4.65
Enterprise value	TWD 1.2B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Medical Devices
Isin	TW0006815004
Last refreshed	2026-05-10
Market cap	TWD 1.2B
Price	TWD 30.6
Price currency	TWD
Sector	Healthcare
Sic	3842
Symbol	tpex/6815
Website	https://www.diamond-biotechnology.cc

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.82%
EV Earnings	-17.01x
EV/FCF	-412.96x
EV/Sales	2.39x
FCF yield	-0.24%
P/B ratio	2.23x
P/S ratio	2.41x
PE Ratio10 Y	54.81x
PE Ratio3 Y	41.93x
PE Ratio5 Y	45.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-17.13%
EBITDA Margin	-11.41%
Gross margin	30.96%
Gross Profit	TWD 155.2M
Gross Profit Growth	-45.36%
Gross Profit Growth Q	-26.64%
Gross Profit Growth3 Y	-22.42%
Gross Profit Growth5 Y	-7.67%
Net Income	TWD -70.3M
Net Income Growth Q	-80.27%
Net Income Growth Years	0%
Pretax Margin	-15.92%
Profit Margin	-14.02%
ROA	-5.58
Roa5y	3.67
ROCE	-11.99
ROE	-12.07
Roe5y	9.12
ROIC	-16.21
Roic5y	5.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-37.19%
Cagr3y	-14.22%
Cagr5y	3.58%
Div CAGR3	17.16%
EPS Growth Q	-81.42
EPS Growth Years	0
Revenue Growth	-34.72x
Revenue Growth Q	-18.09x
Revenue Growth Years	0x
Revenue Growth3 Y	-10.84x
Revenue Growth5 Y	-1.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.52
Assets	TWD 869M
Cash	TWD 209.8M
Current Assets	TWD 621.3M
Current Liabilities	TWD 175.2M
Debt	TWD 197.9M
Debt Equity	TWD 0.37
Debt FCF	TWD -68.32
Equity	TWD 541.8M
Interest Coverage	-16.56
Liabilities	TWD 327.1M
Long Term Assets	TWD 247.7M
Long Term Liabilities	TWD 151.9M
Net Cash	TWD 11.8M
Net Cash By Market Cap	TWD 0.98
Net Debt Equity	TWD -0.02
Tangible Book Value	TWD 540.7M
Tangible Book Value Per Share	TWD 13.69
WACC	5.8

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.28
Inventory Turnover	3.07
Net Working Capital	TWD 161.1M
Quick ratio	2.16
Working Capital	TWD 347M
Working Capital Turnover	TWD 1.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2%
Dividend Growth	39.78%
Dividend Growth Years	2%
Dividend per share	TWD 0.17
Dividend Years	5
Dividend Yield	0.55%
Ex Div Date	2025-08-27
Last Dividend	TWD 0.2
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-37.17%
200-day SMA	53.42
3Y total return	-36.89%
50-day SMA	41.15
50-day SMA vs 200-day SMA	50under200
5Y total return	19.21%
All Time High	114
All Time High Change	-73.15%
All Time High Date	2023-07-05
All Time Low	16.35
All Time Low Change	87.18%
All Time Low Date	2021-10-01
ATR	2.2
Beta	0.39
Beta1y	-0.12
Beta2y	0.07
Ch YTD	-51.43
High	31.05
High52	77.3
High52 Date	2025-10-14
High52ch	-60.41%
Low	29.8
Low52	29.7
Low52 Date	2026-05-07
Low52ch	3.03%
Ma50ch	-25.63%
Price vs 200-day SMA	-42.71%
RSI	32.65
RSI Monthly	34.96
RSI Weekly	27.33
Sharpe ratio	-0.66x
Sortino ratio	-0.94
Total Return	-1.45%
Tr YTD	-51.43
Tr1m	-27.14%
Tr1w	-5.26%
Tr3m	-49.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -85.9M
Operating Income Growth Q	-81.27
Operating margin	-17.13

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	22,865,262%
Net Borrowing	-22,030,000
Shares Insiders	11.21%
Shares Out	39,742,964
Shares Qo Q	-1.53%
Shares Yo Y	2%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -2.9M
Average Volume	151,948.5x
Bv Per Share	13.71
CAPEX	TWD -812,000
Ch1m	-27.14
Ch1w	-5.26
Ch1y	-37.42
Ch3m	-49.75
Ch3y	-38.07
Ch5y	16.32
Ch6m	-54.87
Change	2%
Change From Open	2.68
Close	30
Days Gap	-0.67
Depreciation Amortization	28,720,000
Dollar Volume	1,446,339.6
Earnings Date	2026-05-13
EBIT	TWD -85.9M
EBITDA	TWD -57.2M
EPS	TWD -1.78
F Score	2
FCF	TWD -2.9M
FCF EV Yield	-0.24x
FCF Per Share	TWD -0.07
Financing CF	-44,333,000
Fiscal Year End	December
Founded	2,014
Income Tax	TWD -9.5M
Investing CF	36,993,000
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-06-30
Last Split Date	2025-08-27
Last Split Type	Forward
Ma150	56.55
Ma150ch	-45.89%
Ma20	34.87
Ma20ch	-12.25%
Net CF	-10,005,000
Next Earnings Date	2026-05-13
Open	29.8
Payment Date	2025-09-26
Position In Range	64
Ppne	343,469,000
Price Date	2026-05-08
Ptbv Ratio	2.23
Relative Volume	0.31x
Revenue	501,494,000x
Tax By Revenue	-1.9x
Tr6m	-54.87%
Volume	47,266

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/6815 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$0.17 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

2 consecutive years of growth

Total shareholder yield

-1.4%

Next ex-dividend date: 2025-08-27

Performance

TPEX/6815 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6815?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+11.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.0%

Negative means the company is buying back shares.

Technical

TPEX/6815 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.6

Neutral momentum band

Price vs 200-day MA

-42.7%

50/200-day relationship not available

Beta (5Y)

0.39

Less volatile than the market

Sharpe ratio

-0.66

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6815

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6815 stock rating?

tpex/6815 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6815 analysis?

The full report lives at /stocks/tpex/6815/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6815?

The latest report frames tpex/6815 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6815 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.